| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-322 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-683
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-683
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K20-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C11B11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 |
| filingDate |
2017-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2022-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2022-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-109153693-B |
| titleOfInvention |
Safe-stable plasmalogen, its preparation, and method for judging the non-diseased state of dementia |
| abstract |
The present invention relates to a safe-stable plasmalogen derived from a safe biological material, a preparation thereof, and a method for judging the non-diseased state of dementia using an adult (healthy person) before the onset of dementia as a subject . More specifically, the present invention relates to the incorporation of EPA (eicosapentaenoic acid: a type of ω-3 highly unsaturated fatty acid) into a plasmalogen (hereinafter referred to as "PLs") as an essential requirement. It is formed by minimizing the SN-2 position (undetectable level, substantially 0) of the SN-2 position of the Production of safe-stable plasmalogen, and safe-stable aqueous preparation (emulsion-jelly-granule-powder) obtained by simply nano-emulsifying (or solubilizing) the PLs using safe surfactants New technologies-new products such as the production of and the method of judging the non-diseased state of dementia by oral ingestion of these as an adjuvant or a food, and thereby assisting the long-term suppression-alleviation-prevention of dementia. |
| priorityDate |
2016-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |